scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1040450238 |
P356 | DOI | 10.1038/NG.1068 |
P8608 | Fatcat ID | release_kovze4dvunf6xdoqlv3hc7laue |
P932 | PMC publication ID | 3288669 |
P698 | PubMed publication ID | 22267199 |
P5875 | ResearchGate publication ID | 221768275 |
P50 | author | Christine E. Seidman | Q30123970 |
Benoit G. Bruneau | Q42382236 | ||
Paul Delgado-Olguín | Q79450760 | ||
Jonathan G Seidman | Q88295024 | ||
Danos C Christodoulou | Q114417667 | ||
P2093 | author name string | Alexander Tarakhovsky | |
Xue Li | |||
Yu Huang | |||
P2860 | cites work | Evidence for cardiomyocyte renewal in humans | Q24594522 |
Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas | Q24599661 | ||
Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease | Q24620728 | ||
EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency | Q24645960 | ||
Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis | Q28185761 | ||
Noncompaction of the ventricular myocardium | Q28267994 | ||
Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells | Q28506827 | ||
Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex | Q28507526 | ||
A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart | Q28511081 | ||
A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis | Q28589314 | ||
The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease | Q28752140 | ||
The Polycomb complex PRC2 and its mark in life | Q29547358 | ||
Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
Chromatin remodelling complex dosage modulates transcription factor function in heart development | Q30500285 | ||
Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation | Q34298160 | ||
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss | Q34398395 | ||
Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. | Q36185729 | ||
The genetic basis for cardiac remodeling | Q36241650 | ||
Phenotypic plasticity of adult myocardium: molecular mechanisms | Q36491466 | ||
Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms | Q36810306 | ||
Chromatin structure and the inheritance of epigenetic information | Q37141498 | ||
Epigenetic mechanisms that underpin metabolic and cardiovascular diseases | Q37504694 | ||
Polycomb group proteins set the stage for early lineage commitment | Q37784086 | ||
The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field | Q46196456 | ||
Epigenetics as a unifying principle in the aetiology of complex traits and diseases. | Q51849916 | ||
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. | Q52110894 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
limma | Q112236343 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 343-347 | |
P577 | publication date | 2012-01-22 | |
P1433 | published in | Nature Genetics | Q976454 |
P1476 | title | Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis | |
P478 | volume | 44 |
Q26827943 | A neonatal blueprint for cardiac regeneration |
Q37341931 | A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model. |
Q42027238 | Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells |
Q35757337 | Activation of Six1 Expression in Vertebrate Sensory Neurons |
Q34989584 | Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets |
Q28585968 | Additional sex combs-like family genes are required for normal cardiovascular development |
Q35842165 | Alpha1a-Adrenoceptor Genetic Variant Triggers Vascular Smooth Muscle Cell Hyperproliferation and Agonist Induced Hypertrophy via EGFR Transactivation Pathway |
Q35009145 | Alpha1a-adrenoceptor genetic variant induces cardiomyoblast-to-fibroblast-like cell transition via distinct signaling pathways |
Q48823094 | BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility |
Q38159149 | Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state |
Q41701479 | Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence |
Q36585810 | Braveheart, a long noncoding RNA required for cardiovascular lineage commitment |
Q33667093 | Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. |
Q89068535 | Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development |
Q37172278 | Cardiovascular transcriptomics and epigenomics using next-generation sequencing: challenges, progress, and opportunities |
Q41559939 | Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis |
Q40449640 | Chromatin immunoprecipitation of adult murine cardiomyocytes. |
Q38365973 | Chromatin methylation and cardiovascular aging |
Q38210525 | Chromatin modifications remodel cardiac gene expression |
Q36702439 | Comparative transcriptome profiling of the injured zebrafish and mouse hearts identifies miRNA-dependent repair pathways |
Q41440531 | Congenital diaphragmatic hernias: from genes to mechanisms to therapies. |
Q50599769 | Critical role of YY1 in cardiac morphogenesis. |
Q37179299 | DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation |
Q33639681 | Decoding the complex genetic causes of heart diseases using systems biology |
Q56923471 | Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy |
Q38956469 | Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo |
Q33815911 | Depletion of polycomb repressive complex 2 core component EED impairs fetal hematopoiesis |
Q88137459 | Developing in 3D: the role of CTCF in cell differentiation |
Q93264706 | Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling |
Q50997541 | Divergent Requirements for EZH1 in Heart Development Versus Regeneration. |
Q34453834 | Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease. |
Q42215098 | Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage |
Q33591193 | EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent. |
Q37125672 | ETS factors regulate Vegf-dependent arterial specification |
Q92594529 | EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation |
Q35591404 | EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia |
Q34541488 | EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer |
Q38552464 | Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing |
Q34212728 | Epigenetic mechanisms in heart failure pathogenesis |
Q36185227 | Epigenetic regulation of cardiac development and function by polycomb group and trithorax group proteins |
Q38733315 | Epigenetic regulation of cardiac fibrosis |
Q34449181 | Epigenetic regulation of cardiac myocyte differentiation. |
Q34498966 | Epigenetic regulation of pluripotency and differentiation |
Q38723183 | Epigenetic silencing and activation of transcription: influence on the radiation sensitivity of glioma cell lines |
Q38210945 | Epigenetics in cardiac development, function, and disease. |
Q91251201 | Epigenetics, cardiovascular disease, and cellular reprogramming |
Q39382663 | Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension |
Q43058868 | Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis. |
Q39813120 | Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice |
Q48097604 | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury |
Q50025141 | Ezh2 is not required for cardiac regeneration in neonatal mice. |
Q35748770 | Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation |
Q42136235 | Ezh2 restricts the smooth muscle lineage during mouse lung mesothelial development. |
Q34999341 | Ezh2-mediated repression of a transcriptional pathway upstream of Mmp9 maintains integrity of the developing vasculature. |
Q94538321 | FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling |
Q39014872 | From profiles to function in epigenomics. |
Q35651402 | Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease |
Q42376126 | Genetic and Epigenetic Profiling Reveals EZH2-mediated Down Regulation of OCT-4 Involves NR2F2 during Cardiac Differentiation of Human Embryonic Stem Cells. |
Q90679951 | Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease |
Q30367427 | Genetic networks governing heart development. |
Q37634284 | High throughput in vivo functional validation of candidate congenital heart disease genes in Drosophila |
Q50446893 | Histone demethylases Kdm6ba and Kdm6bb redundantly promote cardiomyocyte proliferation during zebrafish heart ventricle maturation. |
Q27014505 | Histone methylations in heart development, congenital and adult heart diseases |
Q92348528 | Histone methyltransferase SMYD2: ubiquitous regulator of disease |
Q36923943 | Hyperoxia-induced hypertrophy and ion channel remodeling in left ventricle |
Q26750525 | Insulin-like growth factors and their potential role in cardiac epigenetics |
Q37724099 | Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis |
Q60909393 | Intergenerational inheritance of high fat diet-induced cardiac lipotoxicity in Drosophila |
Q37591520 | Interplay of chromatin modifications and non-coding RNAs in the heart |
Q26865493 | Investigating the transcriptional control of cardiovascular development |
Q38921946 | Lineage specific expression of Polycomb Group Proteins in human embryonic stem cells in vitro |
Q36160621 | Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes. |
Q33853875 | Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy |
Q63681786 | Loss of the Polycomb group protein Rnf2 results in derepression of tbx-transcription factors and defects in embryonic and cardiac development |
Q92634851 | Maternal Exposure to High-Fat Diet Induces Long-Term Derepressive Chromatin Marks in the Heart |
Q33726992 | Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer |
Q39144268 | MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. |
Q39720055 | MicroRNAs in a hypertrophic heart: from foetal life to adulthood. |
Q42388103 | Muscles cannot break a NuRDy heart. |
Q38594002 | Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy |
Q37336899 | MyoD reprogramming requires Six1 and Six4 homeoproteins: genome-wide cis-regulatory module analysis |
Q27320793 | Normal formation of a vertebrate body plan and loss of tissue maintenance in the absence of ezh2. |
Q90290390 | Novel Insight Into the Epigenetic and Post-transcriptional Control of Cardiac Gene Expression by Thyroid Hormone |
Q38116933 | Organogenesis of the vertebrate heart |
Q26821792 | PRC2 during vertebrate organogenesis: a complex in transition |
Q47402982 | Polycomb repression complex 2 is required for the maintenance of retinal progenitor cells and balanced retinal differentiation |
Q37025919 | Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells |
Q97424871 | RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells |
Q38787760 | Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes. |
Q35234488 | Readers, writers, and erasers: chromatin as the whiteboard of heart disease |
Q26829774 | Recent developments in cardiovascular genetics and genomics |
Q45098841 | Regulation of Six1 expression by evolutionarily conserved enhancers in tetrapods |
Q42135241 | Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development |
Q34235662 | Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development |
Q41947424 | Ring1b bookmarks genes in pancreatic embryonic progenitors for repression in adult β cells |
Q92139503 | Role of Nkx2.5 in H2O2-induced Nsd1 suppression |
Q91640811 | Role of the PRC2-Six1-miR-25 signaling axis in heart failure |
Q38185265 | Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis |
Q30411046 | Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy. |
Q36133874 | Sequential Binding of MEIS1 and NKX2-5 on the Popdc2 Gene: A Mechanism for Spatiotemporal Regulation of Enhancers during Cardiogenesis |
Q38086222 | Signaling and transcriptional networks in heart development and regeneration |
Q37257403 | Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. |
Q38184513 | Six1: a critical transcription factor in tumorigenesis |
Q42503789 | Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration |
Q27676610 | Structure-function analyses of the human SIX1–EYA2 complex reveal insights into metastasis and BOR syndrome |
Q37544984 | The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy |
Q42262138 | The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role on Clinical Dilated Cardiomyopathy |
Q35107900 | The SIX1-EYA transcriptional complex as a therapeutic target in cancer |
Q39002239 | The canonical wnt signal restricts the glycogen synthase kinase 3/fbw7-dependent ubiquitination and degradation of eya1 phosphatase. |
Q40394481 | The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes. |
Q37317831 | The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy |
Q28586308 | The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart |
Q34429947 | The promise of perfect adult tissue repair and regeneration in mammals: Learning from regenerative amphibians and fish. |
Q91834502 | Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods |
Search more.